Search results

ANSTO is proud to announce that a license has been issued by the Therapeutic Goods Administration to produce Lutetium-177 (Lu-177) for use in clinical trials.

ANSTO has secured a $1.62 million Medical Research Future Fund (MRFF) grant under the Australian Brain Cancer Mission’s 2024 Brain Cancer Discovery and Translation program, administered by the Department of Health and Aged Care.  

Unique opportunity to contribute to the long term conservation of Australia’s most iconic landmark: The Sydney Harbour Bridge.

More than 3,200 solar panels have been installed across the rooftops of the Australian Nuclear Science and Technology Organisation’s (ANSTO) Australian Synchrotron in Clayton, offsetting enough power to light up the whole MCG for more than five years.

nandin is ANSTO’s Innovation Centre where science and technology entrepreneurs, startups and graduates meet industry expertise to experiment, co-create, innovate, and commercialise, creating new jobs in the high-growth industries of tomorrow.

ANSTO provides a summary of waste production and consumables for FY2022 - FY2023

The work of the group comprises Radioactivity Measurement Standards, Radioanalytical chemistry, Environmental Radioactivity Measurement Centre, Nuclear security science and Environmental monitoring.

ANSTO offers accelerator-based particle-induced gamma-ray emission techniques to determine total fluorine concentration in a range of solid materials and rapidly screen for the presence of PFAS (perfluoroalkyl and polyfluoroalkyl substances).

Director of the Australian Synchrotron Prof Andrew Peele has been appointed to Australian Mathematical Sciences Board.